{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:16:50Z","timestamp":1760188610270},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,4,1]],"date-time":"1986-04-01T00:00:00Z","timestamp":512697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J, Clin. Microbiol."],"published-print":{"date-parts":[[1986,4]]},"DOI":"10.1007\/bf02013996","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T20:02:19Z","timestamp":1123790539000},"page":"232-235","source":"Crossref","is-referenced-by-count":38,"title":["Evaluation of ciprofloxacin in the treatment ofPseudomonas aeruginosa infections"],"prefix":"10.1007","volume":"5","author":[{"given":"H.","family":"Giamarellou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Galanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dendrinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Stefanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Daphnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. K.","family":"Daikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02013996_CR1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/AAC.25.5.633","volume":"25","author":"A. L. Barry","year":"1984","unstructured":"Barry, A. L., Jones, R. N., Thornsberry, C., Ayers, L. W., Gerlach, E. H., Sommers, H. M.: Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin and nalidixic acid. Antimicrobial Agents and Chemotherapy 1984, 25: 633\u2013637.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013996_CR2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/AAC.23.4.559","volume":"23","author":"R. Wise","year":"1983","unstructured":"Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay-O 9867, a new quinolone derivative, compared with that of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559\u2013564.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013996_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF01977491","volume":"3","author":"G. L. Ridgway","year":"1984","unstructured":"Ridgway, G. L., Mumtar, G., Gabriel, F. G., Oriel, J. D.: The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis and mycoplasmas in vitro. European Journal of Clinical Microbiology 1984, 3: 344\u2013346.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02013996_CR4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/AAC.26.2.208","volume":"26","author":"R. Wise","year":"1984","unstructured":"Wise, R., Lockley, R. M., Webberly, M., Dent, J.: Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrobial Agents and Chemotherapy 1984, 26: 208\u2013210.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013996_CR5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.26.2.245","volume":"26","author":"H. Giamarellou","year":"1984","unstructured":"Giamarellou, H., Galanakis, N., Douzinas, E., Petrikkos, G., El Messidi, M., Papoulias, G., Daikos, G. K.: Evaluation of aztreonam in difficult to treat infections with prolonged post-treatment follow-up. Antimicrobial Agents and Chemotherapy 1984, 26: 245\u2013249.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02013996_CR6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archinte.1981.00340120055012","volume":"141","author":"S. J. Pancoast","year":"1981","unstructured":"Pancoast, S. J., Prince, A. S., Francke, E. L., Neu, H. C.: Clinical evaluation of piperacillin therapy for infection. Archives of Internal Medicine 1981, 141: 1447\u20131450.","journal-title":"Archives of Internal Medicine"},{"issue":"Supplement","key":"BF02013996_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/11.suppl_B.153","volume":"12","author":"S. Olive","year":"1983","unstructured":"Olive, S., Mogabgab, W. J., Holmes, B., Pollock, B., Pauling, B., Beville, R.: Treatment of serious pseudomonas infections with azlocillin. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement: 153\u2013158.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supplement B","key":"BF02013996_CR8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jac\/8.suppl_B.331","volume":"8","author":"G. K. Daikos","year":"1981","unstructured":"Daikos, G. K., Kosmidis, J., Stathakis, C., Giamarellou, H., Douzinas, E., Kastanakis, S., Papathanassiou, B.: Ceftazidime: therapeutic results in various infections and kinetic studies. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement B: 331\u2013337.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supplement","key":"BF02013996_CR9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/clinids\/4.Supplement_3.S650","volume":"4","author":"D. J. Winston","year":"1982","unstructured":"Winston, D. J., Kurtz, T. O., Young, L. S., Busuttil, R. W.: Moxalactam for treatment of nosocomial infections. Reviews of Infectious Diseases 1982, 4, Supplement: 650\u2013655.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF02013996_CR10","first-page":"219","volume":"7","author":"H. Giamarellou","year":"1981","unstructured":"Giamarellou, H., Koumaditis, A., Dispiraki, K., Xefteri, H., Daikos, G. K.: Therapeutic effectiveness and pharmacokinetics of cefsulodin in multiresistantPseudomonas aeruginosa infections. Drugs under Experimental and Clinical Research 1981, 7: 219\u2013226.","journal-title":"Drugs under Experimental and Clinical Research"},{"key":"BF02013996_CR11","first-page":"1775","volume":"12","author":"H. Giamarellou","year":"1984","unstructured":"Giamarellou, H., Efstratiou, A., Tsagarakis, J., Petrikkos, G., Daikos, G. K.: Experience with ciprofloxacin in vitro and in vivo. Arzneimittel Forschung 1984, 12: 1775\u20131778.","journal-title":"Arzneimittel Forschung"}],"container-title":["European Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02013996.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02013996\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02013996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T22:25:33Z","timestamp":1557786333000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02013996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,4]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,4]]}},"alternative-id":["BF02013996"],"URL":"https:\/\/doi.org\/10.1007\/bf02013996","relation":{},"ISSN":["0722-2211","1435-4373"],"issn-type":[{"value":"0722-2211","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,4]]}}}